"

首存18送58彩金|首存18送58一倍流水|首存1送38拥有全球最顶尖的原生APP,每天为您提供千场精彩体育赛事,首存18送58彩金|首存18送58一倍流水|首存1送38更有真人、彩票、电子老虎机、真人电子竞技游戏等多种娱乐方式选择,首存18送58彩金|首存18送58一倍流水|首存1送38让您尽享娱乐、赛事投注等,且无后顾之忧!

  • "
    Contact us

    China National Pharmaceutical
    Group Corporation(SINOPHARM)
    Address: No.20 Zhichun
    Road, Haidian District, Beijing, China
    Postal Code: 100191
    Tel:86-10-82287727
    Fax: 86-10-62033332
    Website: http://www.kirlitezgah.com

     

    Learn more >>

    Sinopharm News

    GeneoDx Detection Kits Get EU Approval

    Post Time:2020-03-21 [Large Middle Small] View:

    On March 14th, Sinopharm CNBG Shanghai GeneoDx got the EC Declaration of Conformity of their self-developed 2019-nCoV nucleic acid detection kits (real time PCR), meaning the detection kits meet the requirements of European medical device conformity and are entitled to enter the EU market.

    Sinopharm CNBG GeneoDx responded immediately to the outbreak of COVID-19 and started R&D of its detection kits. It was the first to develop COVID-19 nucleic acid detection kits and submit to the China CDC for testing, and was among the first suppliers of such detection kits recommended by the National Health Commission’s Guidance for Novel Coronavirus Pneumonia Laboratory Testing Technology, and among the first ones to obtain the medical device registration from the National Medical Products Administration.

    During the epidemic, Sinopharm CNBG GeneoDx has been in full production and supplied detection kits to the front lines in all provinces to ensure the prevention and control of the epidemic, playing an essential role in precision diagnosis and safeguarding national health. 


    As an enterprise with a centenary history, Sinopharm CNBG acted proactively in terms of diagnosis, treatment, R&D in vaccines and antibodies, staging its responsibility and the sense to undertake as the “national team” of bio-products. Sinopharm CNBG first came up with the convalescent plasma therapy and set the criteria for making the convalescent plasma. It dispatched 44 plasma collecting teams and set up 50 plasm collecting spots. The outcome of this therapy was recognized by the State Council Joint Prevention and Control Mechanism.


    As the pandemic continued to spread globally, Sinopharm CNBG dispatched an expert to join the team set up by China Red Cross Society to aid Italy onsite in fighting the pandemic. With GeneoDx’s detection kits approved with CE, it is now able to assist the world in this fight.

    首存18送58彩金|首存18送58一倍流水|首存1送38